Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Murphy Polly A. exercised options for 29,600 Atea Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 18, 2026 · Filed Jun 23, 2026
On Jun 18, 2026, Murphy Polly A. (Director) exercised options for 29,600 Atea Pharmaceuticals, Inc. shares, leaving 121,745 shares. Filed Jun 23, 2026 (Form 4).
- Options exercised
- 29,600 shares
- Holding after
- 121,745 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Common Stock | Option exercise | 29,600 | 121,745 | Direct |
Source
Related
- Atea Pharmaceuticals, Inc.
- Murphy Polly A.
- Atea Pharmaceuticals, Inc. shareholders
- Form 4/A · Murphy Polly A. · May 21, 2026
- Form 4 · Murphy Polly A. · May 20, 2026
- Schedule 13G · Tang Capital Management LLC · Oct 6, 2026
- Form 4 · Lucidi Bruno · Jun 23, 2026
- Form 4 · Berger Franklin M · Jun 23, 2026
- Form 4 · Duncan Barbara Gayle · Jun 23, 2026
- Form 4 · Adams Jerome M. · Jun 23, 2026